Market Overview

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades
Related FOE
Mid-Afternoon Market Update: Evoke Pharma Drops On Failed Phase 3 EVK-001 Data; ParkerVision Shares Spike Higher
12 Biggest Mid-Day Losers For Monday
Related ABX
Buying Barrick Gold, Selling Apple: Fast Money Picks For August 25
Will The Rally In Barrick Gold Continue?
Barrick Gold Still has Upside to Offer (GuruFocus)

Analysts at Deutsche Bank upgraded Ferro (NYSE: FOE) from “hold” to “buy.” The target price for Ferro is set to $8. Ferro's shares closed at $6.73 yesterday.

Analysts at BMO Capital upgraded Barrick Gold (NYSE: ABX) from “underperform” to “market perform.” The target price for Barrick Gold has been raised from $17 to $18. Barrick Gold's shares closed at $16.81 yesterday.

Analysts at Aegis Capital upgraded Cubist Pharmaceuticals (NASDAQ: CBST) from “hold” to “buy.” The target price for Cubist Pharmaceuticals is set to $70. Cubist's shares closed at $64.80 yesterday.

Analysts at Cantor Fitzgerald upgraded LinkedIn (NYSE: LNKD) from “hold” to “buy” The target price for LinkedIn has been raised from $170 to $250. LinkedIn's shares closed at $213.00 yesterday.

Latest Ratings for FOE

DateFirmActionFromTo
Jan 2016Deutsche BankMaintainsBuy
Jan 2016Seaport Global SecuritiesUpgradesAccumulateBuy
Sep 2015OppenheimerInitiates Coverage onOutperform

View More Analyst Ratings for FOE
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (CBST + ABX)

View Comments and Join the Discussion!